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Summary
Irregular menstrual cycles, reduced responses to exogenous hor-
monal treatments, and altered endocrine profiles (high FSH/high
LH/low AMH) are observed in women with increasing age before
menopause. In this study, because the granulosa cell-specific Nrg1
knockout mice (gcNrg1KO) presented ovarian and endocrine
phenotypes similar to older women, we sought to understand
themechanismsofovarianagingand todevelopanewstrategy for
improving fertility in older women prior to menopause. In the
ovary of 6-month-old gcNrg1KOmice, follicular development was
blocked in bilayer secondary follicles and heterogeneous cells
accumulated in ovarian stroma. Theheterogeneous cells in ovarian
stroma were distinguished as two different types: (i) the LH
receptor-positive endocrine cells and (ii) actin-rich fibrotic cells
expressing collagen. Both the endocrine and fibrotic cells disap-
peared following long-term treatment with a GnRH antagonist,
indicating that the high levels of serum LH induced the survival of
both cell types and the abnormal endocrine profile to reduce
fertility.Moreover, follicular development to the antral stageswas
observedwith reduced LH and the disappearance of the abnormal
stromal cells. Mice treated with the GnRH antagonist regained
normal, recurrent estrous cycles and continuously delivered pups
for at least for 3 months. We conclude that endocrine and matrix
alternations occur within the ovarian stroma with increasing age
and that abolishing these alternations resets the cyclical release of
LH. Thus, GnRH antagonist treatments might provide a new,
noninvasive strategy for improving fertility in a subset of aging
women before menopause.
Key words: estrus cycle; female fertility; gonadotropins;
ovarian aging; ovarian stroma; steroidogenesis.
Introduction
Female fertility declines with increasing age not only in humans but also
in other species including mice and livestock animals. Fertility of women
decreases slightly around the age of 30 (van Noord-Zaadstra et al.,
1991), but is clearly evident at a median age of 40 (Bongaarts, 1982).
Several reports indicate that the decline in fertility with age is associated
with the loss of follicles and the poor quality of oocytes in these follicles
(Gosden et al., 1983; Faddy et al., 1992). However, there are about
10 000 follicles in ovary of women over 40 years of age (Faddy et al.,
1992) and woman beyond 40 years can get pregnant following
hormone treatments used in assisted reproduction technology (ART)
(Manson & Martin, 2001; Klipstein et al., 2005). These observations
indicate that the decline in fertility in women over 40 years of age until
menopause is related not only to the loss of follicles in ovary but also to
either abnormal hormone levels or abnormal responses to hormones in
the hypothalamic–pituitary–gonadal axis.
In women, menstrual cycles become irregular at about 40 years of
age (Treloar, 1981), although it takes another 10 years until menstrual
cycles cease (den Tonkelaar et al., 1998). Abnormal estrous cycles are
also observed with increasing age in mice (Nelson et al., 1981), rats
(Fugo & Butcher, 1971), and cattle (Malhi et al., 2005). Malhi et al.
(2005) reported that the estrous cycle is prolonged due to altered
periodic changes of estradiol and FSH, which results in the extinction of
normal estrous cycles (Malhi et al., 2005). Beginning around 10 months
of age, female mice also exhibit an extended estrous phase (Nelson
et al., 1981) and a poor response to standard super-ovulatory regimens
of FSH/eCG and LH/hCG; the number of ovulated oocytes is significantly
lower than that in younger mice (Holinka et al., 1979; Mori, 1979). The
ability of follicles to respond to both gonadotropins is acquired at the
secondary stage when follicles have multiple layers of granulosa cells
(Dierich et al., 1998), suggesting that follicular development beyond the
secondary stage is suppressed, resulting perhaps in the accumulation of
secondary follicles in the ovary of aged mice and women. The
development from secondary to antral follicles is dependent on the
basal levels of serum FSH and LH that are regulated by hypothalamic
release of GnRH as well as by ovarian factors, such as inhibin B, estradiol,
and progesterone (Ling et al., 1987; Couse & Korach, 1999).
Based on these considerations, we hypothesized that irregular
secretion of gonadotropins and altered ovarian feedback mechanisms
might impact ovarian follicular development in aged female mice leading
to abnormal estrous cycles. Unfortunately, there is limited information
about the relationship of the ovarian–hypothalamic–pituitary axis and
follicular development in aging female mice. Most studies focus on the
decline of female fertility and the loss of follicles/oocytes in ovary; only a
few reports mention the process by which ovarian functions change with
increasing age.
Anti-Mullerian hormone (AMH) is expressed at high levels in pre-
antral follicles and, based on the decrease in AMH in serum of aging
women, it is used as an indicator of the follicle reserve. However, AMH
levels are not different in mice between 10 and 14 months of age and
mice that are younger (Kevenaar et al., 2006). Therefore, it is thought
that wild-type mice are not a relevant model to understand the
mechanisms by which ovarian function declines with increasing age in
older women. In our previous studies, the expression of neuregulin 1
(NRG1) was observed in LH-stimulated granulosa cells during ovulation.
In the granulosa cell-specific Nrg1 KO mice (gcNrg1KO), rupture of the
follicular wall occurs; however, not only the number of pups delivered
declined in the mutant mice but also the time interval between litters
was prolonged in the mutant mice more than 6 months of age
(Kawashima et al., 2014). Thus, we used this mutant mouse model to
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determine the underlying causes of the prolonged intervals between
litters in these mice older than 6 months age and to examine whether
the mechanisms occurring in the mutant mice might also apply to altered
fertility in aged wild-type (WT) mice. Finally, we developed a method to
restore the normal ovarian function and fertility in aged mice.
Results
The decline of fertility with increasing age is accelerated in
gcNrg1KO mice
In WT mice, the number of pups born per month decreased linearly
from 9 to 15 months of age (Fig. 1A). The number of pups delivered
from each pregnancy also decreased significantly with age (Fig. 1B).
The interval between pregnancies was about 30 days; however, the
interval increased after 12 months of age with large variations
(Fig. 1C). In the granulosa cell-specific Nrg1KO (gcNrg1KO) mice, the
number of pups born per month was significantly lower than that in
WT mice during all mating periods with linear decreases observed from
6 to 8 and then 10 to 13 months of age after which very few pups
were born (Fig. 1A). Reduced fertility in the gcNrg1KO mice was
associated with both the longer interval between pregnancies and the
decreased number of pups delivered (Fig. 1A–C). Specifically, the
interval between pregnancies was highly variable in gcNrg1KO mice
and exceeded more than 50 days after 12 months of age (Fig. 1C).
When mice were injected with super-ovulatory doses of eCG followed
48 h later with hCG, the number of ovulated COCs in oviduct of
6-month-old gcNrg1KO mice was lower compared with that in
6-month-old WT mice (Fig. 1D). A low number of ovulated oocytes
were also detected in 12-month-old WT mice (Fig. 1D). Fertilization
rates of oocytes and the competence of these fertilized oocytes to
develop to the blastocyst stage were significantly lower in oocytes
recovered from 6-month-old gcNrg1KO or 12-month-old WT mice than
those in 6-month-old WT, respectively (Fig. 1E,F).
Abnormal estrous cycles occur with increasing age
Estrous cycles of 4 or 5 days occurred in 6-month-old WT mice (Figs 2A
and S1, Supporting information). However, the estrous cycles in
gcNrg1KO mice beyond 6 months of age and WT mice beyond
12 months of age were abnormal. Rascop et al. (1966) defined ‘weak
estrus’ (WE) when not only many cornified epithelial cells but also
leukocytes were observed in the vaginal smear; hence, gcNrg1KO mice
beyond 6 months and WT mice beyond 12 months presented weak
estrus (Fig. S1, Supporting information). In addition, the estrous cycle of
gcNrg1KO over 6 months or WT mice older than 12 months, respec-
tively, was significantly longer than that in 6- to 12-month-old WT mice
(Fig. 2A).
To determine the underlying causes of the onset of abnormal estrous
cycle length of gcNrg1KO mice, ovarian transplantation experiments
were carried out. When ovaries of 6-month-old gcNrg1KO mice were
transplanted under the ovarian bursa of 3-month-old WT mice, the
estrous cycle was prolonged and similar in length to that observed in the
gcNrg1KO mice. Conversely, when ovaries of WT mice were trans-
planted into the mutant mice, normal estrous cycle length was observed,
indicating that the WT ovary restored normal cycle length in the mutant
mice. The estrous cycle in 12-month-old WT mice was also normalized
by the transplantation of ovaries from 3-month-old WT mice (Fig. 2B),
indicating that the irregular estrous cycles caused by the abnormal
functions of Nrg1-mutant ovaries and by the alternation of ovarian
function with increasing age.
In 6-month-old WT mice, serum levels of FSH decreased from diestrus
to estrus and this was associated with increased levels of inhibin B and
estradiol 17b (E2), a pattern observed in mice with normal fertility
(Figs 2C and S2, Supporting information). However, gcNrg1KO mice
showed a stable endocrine condition, elevated levels of FSH and E2, and
lower levels of inhibin B on the day of weak estrus. Serum levels of FSH,
LH, E2, and testosterone (T4) were higher than those of their basal levels
in 6-month-old WT mice. The level of FSH was further increased in
12-month-old gcNrg1KO as compared with that of gcNrg1KO mice at
6 months (Figs 2C and S2, Supporting information). No significant
difference of serum levels of AMH level was observed between WT and
mutant mice at 3 months of age. However, serum levels of AMH were
significantly lower in 6-month-old or 12-month-old gcNrg1KO mice as
compared with that in same age of WT mice, respectively (Fig. 2D).
Ovarian morphology changes with increasing age and is
accelerated in gcNrg1KO mice
In the ovary of 6-month-old WT mice, many antral follicles and corpora
lutea were observed (Fig. 3A), and picrosirius red (PSR) staining of
collagen (I and III) fibers was intense in the basal lamina of growing
follicles and in the stroma; only weak signals were detected in corpora
lutea (Fig. 3A0). In the ovary of 6-month-old gcNrg1KO mice, large
round cells in the stroma were stained by PSR (Fig. 3B0, D’). The PSR-
positive cells were also rhodamine phalloidin positive, a marker of F-actin
(Fig. 3B″,D″, Fig. S3, supporting information). PSR and rhodamine
phalloidin staining increased in the stroma of 12-month-old mutant mice
(Fig. S3, supporting information). In the ovary of 6- and 12-month-old
gcNrg1KO mice, fewer secondary follicles and antral follicles were
observed; however, the number of bilayer stage secondary follicles was
significantly higher than that in ovaries of WT mice of the same age
(Figs 3B,D and S4, Supporting information). In association with the
increased number of PSR-stained cells, the expression of Col3a1 mRNA
in ovaries of 12-month-old WT mice was significantly higher than that in
ovaries of 3-month-old WT mice. The induction of Col3a1 was
Fig. 1 The decline of fertility with increasing age is accelerated in gcNrg1KO mice. (A) The total number of pups born per month in each gcNrg1KO (KO) female and WT
male mating pair or each Nrg1flox/flox (WT) female and WT male mating pair were determined during a 15-month breeding period. Five pairs were analyzed in each genotype.
*denotes a significant difference between genotypes (P < 0.05). (B) The average number of pups per litter was calculated in each gcNrg1KO (KO) female and WT male
mating pair or each Nrg1flox/flox (WT) female and WT male mating pairs. Five pairs were prepared in each genotype. *denotes a significant difference between genotypes
(P < 0.05). In the box plot: bar = median, box = 25th to 75th percentiles, whiskers = 10th and 90th percentile. (C) The intervals between pregnancies were calculated in
each gcNrg1KO (KO) female and WT male mating pair or each Nrg1flox/flox (WT) female and WT male mating pair. Five pairs were prepared in each genotype. The data were
statistically analyzed by Bartlett’s test. *denotes a significant difference between genotypes (P < 0.05). In the box plot: bar = median, box = 25th to 75th percentiles,
whiskers = 10th and 90th percentile. (D, E, F) The number of ovulated oocytes (D), the percent of fertilization oocytes per ovulated oocytes (E), and the percent of blastocysts
per fertilization oocytes (F) in 6-month-old WT, 6-month-old gcNrg1KO, and 12-month-old WT. Each mouse at diestrus was injected ip with 4 IU eCG followed by 48 h later
with 5 IU of hCG. After 16 h, the ovulated COCs were collected from oviducts and then were subjected to in vitro fertilization. Black bars indicated mean value of each
percent. *, P < 0.05, significant differences were observed compared with 6-month-old WT.
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accelerated in ovaries of the mutant mice; the expression in the ovary of
6-month-old gcNrg1KO mice was significantly higher than that of
3-month-old gcNrg1KO mice (Fig. 3F).
Ovarian functions change with increasing age and are
accelerated in gcNrg1KO mice
The expression of Fshr mRNA, a marker of multiple layers of secondary
follicles and antral follicles, decreased in ovaries of WT mice with
increasing age; decreased Fshr expression was accelerated in gcNrg1KO
and appears to reflect the early alteration of follicular development in
these mutant mice (Fig. 4A). However, the expression of markers of
secondary and antral follicles, Lhcgr, Cyp11a1, Cyp17a1, and Cyp19a1,
was significantly higher in ovaries collected from mutant mice at
6 months of age as compared with expression in ovaries of younger
mutant mice or same age WT mice. Significant increases in the
expression of these genes were also observed in the ovaries of 12-
month-old WT and gcNrg1KO mice (Fig. 4A). To determine which cell
type(s) expressed the markers in ovary, IHC studies were carried out
using anti-CYP19a1, anti-CYP17a1, and anti-LHCGR antibodies. The
positive signals for anti-CYP19a1 antibody and anti-LHCGR antibody
were observed in granulosa cells of pre-ovulatory follicles in the ovary of
eCG-primed WT mice (Fig. S5, Supporting information). The signals for
anti-CYP17a1 antibody were localized in theca cells of antral follicle in
the ovary of eCG-primed WT mice (Fig. S5, Supporting information).
However, in ovaries of the gcNrg1KO mice, intense staining for these
follicular markers was observed in cells within the ovarian stroma rather
than within ovarian follicles (Fig. 4B). The percent of anti-LHCGR-positive
cells in ovarian stroma of gcNrg1KO mice was significantly higher than
that in same age mice (Fig. 4C). The increase in anti-LHCGR-positive cells
in ovarian stroma was observed ovaries of WT and mutant mice with
increasing age (Fig. 4C).
GnRH antagonist treatment restored normal functions of the
ovary in 6-month-old gcNrg1KO
The cells expressing LH receptor accumulated in the ovarian stroma with
increasing age (Fig. 4B), and serum levels of LH and FSH in gcNrg1KO
mice were consistently higher than those in WT mice (Fig. 2C), indicating
that the function and/or survival of these cells might be dependent on
the gonadotropin stimulation. To analyze this hypothesis, we suppressed
gonadotropin secretion from pituitary gland by GnRH antagonist
treatment.
Following 8 days of treatment with the GnRH antagonist, the mutant
mice entered a normal estrous cycle, progressing from estrus to diestrus
rather than from estrus to weak estrus (Fig. 5A). With the return of
normal estrous cycles we observed, reduced PSR staining (indicative of
decreased collagen) in the stroma, increased staining of anticleaved
caspase 3 (indicative of increased apoptosis), reduced stromal cell
staining of anti-LHR (indicative of decreased LH-target cells) and anti-
CYP19 (indicative of decreased estrogen production) (Figs 5B and S6A,
Supporting information), and decreased serum levels of LH, FSH,
estradiol, and testosterone (Fig. 5C). At day 8 after GnRH antagonist
treatment, the percent of multilayered secondary follicles (Fig. S6B,
Supporting information) and serum levels of AMH (Fig. 5C) were
significantly increased as compared with those before the treatment.
The GnRH antagonist treatment was terminated after 8 days when all
of the treated gcNrg1KO mice exhibited a diestrous smear rather than a
weak estrous smear. The first estrus was observed 5 days after the final
GnRH antagonist injection, and estrus was observed every 4 or 5 days
thereafter (Fig. 5A). Antral follicles were observed in the ovary of
gcNrg1KO at the end of GnRH antagonist treatment, and antral follicles
developed to large antral follicles 4 days later (Fig. 5B). Injections of hCG
on pro-estrous increased the number of ovulated COCs in the oviducts
of mutant mice as compared with that of age-matched nontreated
mutant mice (Fig. 5D). To determine the fertility of the gcNrg1KO mice
after the GnRH antagonist treatment, the mutant mice were mated with
WT male mice for 3 months. The total number of pups delivered per
pregnancy and the number of pregnancies increased following the
GnRH antagonist treatment regimen (Fig. 5E,F). The extended GnRH
antagonist treatment also normalized the estrous cycles of 12-month-old
WT (Fig. S7A, Supporting information), and the number of pregnancies
and the number of pups per pregnancy in 12-month-old WT were also
increased (Fig. S7B,C, Supporting information).
Discussion
The deletion of Nrg1 in granulosa cells of periovulatory follicles does not
alter ovulation, cumulus cell–oocyte complex (COC) expansion or oocyte
meiotic progression to the metaphase II (MII) stage; however, the
matured oocytes in the mutant mice have a low cytostatic activity to
arrest at the MII stage (Kawashima et al., 2014). After ovulation,
spontaneous re-resumption of meiosis is induced prematurely within 4 h
resulting in a low pregnancy rate in gcNrg1KO female mice (Kawashima
et al., 2014). The recurrent succession of estrous cycles related to the
low pregnancy rate appears to create changes in ovarian and pituitary
functions that accelerate the accumulation of endocrine cells and the
expansion of fibrous tissue in the stroma of gcNrg1KO mice compared to
events observed in the ovarian stroma of the WT mice.
Specifically, the mutant mice exhibit premature signs of aging that
are eventually observed in older WT mice, including prolonged intervals
between estrus; a reduced response to FSH; elevated serum levels of LH,
FSH, and estradiol; and reduced levels of inhibin B. These changes
except for the serum level of estradiol are often observed in women with
increasing age (Santoro et al., 1996; Broekmans et al., 2007). In
postmenopausal women, the level of estradiol was dramatically lower
Fig. 2 The abnormal estrous cycle is induced by the changes in the ovary that occur with increasing age. (A) Estrous cycle length (in days) in WT and gcNrg1KO mice
3–12 months old . Smears were obtained daily between 09:00 and 10:00 am. The fire-polished, shortened tip of a Pasteur pipet was placed at the vagina. *denotes a
significant difference (P < 0.05). In the box plot: bar = median, box = 25th to 75th percentiles, whiskers = 10th and 90th percentile. (B) Estrous cycle length (in days) in the
mice following transplantation of ovaries between 6-month-old WT and gcNrg1KO or between 6-month-old WT and aged WT (12-month-old). *denotes a significant
difference (P < 0.05). (C) Serum levels of FSH, LH, estradiol (E2), testosterone (T4), inhibin B, and progesterone (P4) in WT and gcNrg1KO. The samples of 6-month-old WT
were collected at diestrus and estrus. In 6-month-old gcNrg1KO mice and 12-month-old mice of both genotypes, the samples were collected in weak estrus because other
estrus periods were rarely observed. The levels of each hormone were measured by EIA kit. N = 4 animals for each genotype. Values are represented as the mean  SEM of
four replicates. *denotes the significant differences observed (P < 0.05). (D) Serum levels of AMH in each age of WT and gcNrg1KO mice. The samples were collected 2 days
after estrus, and AMH levels were measured by EIA kit. N = 4 animals for each genotype. Values are represented as the mean  SEM of four replicates. *denotes the
significant differences observed between genotypes at the same age (P < 0.05). Different superscripts denote significant differences among the age in each genotype
(P < 0.05).
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than that in younger women with reduce levels of inhibin B (Lee et al.,
1988). However, it has been reported that the level of estradiol is
increased during the specific period before menopause, and the level of
estradiol was significantly higher in women that exhibit a reduced
response to FSH than in normal women among middle-aged women
(from 38 to 42 years old) (Buyalos et al., 1997). Additionally, low
responder patients, who exhibit a reduced response to exogenous FSH,
also have fewer matured oocytes and the quality of the oocytes was
poor compared to that observed in normal women (Jenkins et al.,
1991). In this study, the number of oocytes fertilized and capable of
developing to the blastocyst stage was significantly lower in 6-month-
old gcNrg1KO female mice as compared in those in the same age of WT
mice. Thus, the mutant mice appear to provide a model to help explain
not only the mechanisms leading to the decline in fertility with
increasing age but also the reduced response of women to FSH with
increasing age.
In the mutant mice, the endocrine and fertility changes that occur
with increasing age were associated with the accumulation of aberrant
endocrine cells in the ovarian stroma and the high expression of
Cyp17a1, Cyp19a1, and Lhcgr in the stromal endocrine cells. The
accumulation and function of these cells appeared to be driven, in
part, by elevated LH. For example, the accumulation of endocrine cells
in the ovarian stroma has previously been observed in ovaries of LH
beta (LHb) over-expressing mice with increasing age (Risma et al.,
1995). The importance of these stromal cells, as well as the
gonadotropins, to the aging phenotype is also revealed by prolonged
treatment of the aging mutant (6-month-old) and WT (12-month-old)
mice with a GnRH antagonist. Notably, the antagonist treatment
caused apoptosis and reduced expression of steroidogenic genes in the
aberrant stromal endocrine cells and reduced the area of fibrosis
tissue. The importance of the endocrine cells within the stroma to the
aging phenotype is shown by the transplantation experiments,
indicating that these endocrine cells in the aging ovaries have over-
ridden and superseded the ability of growing follicles to regulate the
ovarian–pituitary–hypothalamic axis, such that high LH and FSH
maintain elevated estradiol and testosterone production by these
stromal cells.
The fibrosis in the ovarian stroma and increased levels of basal LH are
also observed in women at advanced age (Gredmark et al., 1995; Matt
et al., 1998) and in the patients with hypersecretion of LH (Schildkraut
et al., 1996). In addition, LH-induced androgen may be related to
fibrosis within the ovary (Barbieri et al., 1986; Futterweit & Deligdisch,
1986). Thompson & Adelson (1993) reported that the androgen
production occurred in ovarian stromal cells and increased with
advanced age in women (Thompson & Adelson, 1993). Furthermore,
ovarian stromal fibrosis was observed frequently in ovaries of hyperan-
drogenic patients, and the main source of androgen occurred in the
stromal tissue (McNatty et al., 1980). In rodents, fibrosis is observed with
increasing age (Briley et al., 2016) and treatment with exogenous
testosterone induced fibrosis in the ovarian stroma (Miao et al., 2008).
Our studies show that the stromal fibrosis also occurs in the gcNrg1KO
mice after 6 months of age and in WT mice at 12 months of age when
both LH and androgens are chronically high and that this condition was
reversed by prolonged treatment of GnRH antagonist. Collectively, the
data in mice and women suggest that the fibrosis of ovarian stroma is
dependent on LH-androgen signaling and may be commonly induced in
ovaries with increasing age.
However, the relationship between the growth of fibrosis tissue in
the ovarian stroma and the suppression of follicle growth in the aging
ovary has remained unclear. Follicular development is initiated by
primordial follicle activation (Fortune et al., 2000) followed by progres-
sion to the secondary follicles stage that is dependent, in part, on
oocyte-secreted factors, such as GDF9 and BMP15 (Dong et al., 1996;
Galloway et al., 2000). Further follicular development from secondary
follicles is dependent on gonadotrophins, especially FSH (Dierich et al.,
1998; Abel et al., 2000; Pakarainen et al., 2005). In the present study,
increased fibrosis within the ovarian stroma was associated with the
increased numbers of bilayer of secondary follicles, indicating that the
fibrosis might suppress pre-antral follicular development (Wood et al.,
2015). Importantly, the long-term treatment of GnRH antagonist not
only increased the number of multilayer secondary follicles, but also
reduced the fibrosis and the presence of aberrant endocrine cells in the
stroma of the mutant mice. Thus, LH-induced fibrosis in the ovarian
stroma appears to alter the follicular-stroma microenvironment to alter
secondary follicle growth. Recently, Kawamura et al. (2013) reported
that the growth of secondary follicles to the multilayer stage in ovaries
of low FSH-responding women was induced by the physical stimulation
(cutting ovary) in vitro (Kawamura et al., 2013). They successfully
promoted follicle growth and performed in vitro fertilization, and a
healthy baby was delivered (Kawamura et al., 2013). The mechanisms
by which mechanical stress appear to suppress follicle growth were
explained by YAP/TAZ mechanotransduction system in granulosa cells
(Kawamura et al., 2013). Information that an actin polymerization-
enhancing drug can induce follicular development would support the
above idea (Cheng et al., 2015); however, in the present study, the
strong intensity of F-actin was only observed in the ovarian stroma and
not within follicles. However, there are no reports yet relating the roles
of mechanotransduction and the actin polymerization-YAP/TAZ path-
way during follicular development process in ovary using the knockout
mice model. Therefore, further studies are required to determine the
relationship among the abnormal endocrine condition, the growth of
fibrosis tissue in ovarian stroma, and the suppression of follicular
development in pre-antral follicles. However, our studies indicate the
restoration of fertility, the decrease in fibrosis, and growth of secondary
follicles in ovarian stroma of aged ovary can be achieved by resetting
serum levels of LH.
Fig. 3 Changes in ovarian morphology are accelerated with increasing age in the gcNrg1KO mice. (A,B,C,D) Picrosirius red (PSR) staining of 6-month-old WT (A), 6-month-
old gcNrg1KO (B), 12-month-old WT (C), and 12-month-old gcNrg1KO (D) ovaries. Ovaries collected 2 days after estrus were fixed by 4 % paraformaldehyde. The sections
were stained by picrosirius red and eosin. The scale bar for images in (A–D) is 400 lm. (A0–D0 and A″–D″) are higher magnification images from specific regions of the
ovarian stroma that are boxed in (A–D). (A″–D″) are fluorescence images using rhodamine phalloidin that recognizes F-actin and DAPI that recognizes nuclei, with constant
settings that were established for the 12-month-old gcNrg1KO (D″). Scale bars in (A0–D0 and A″–D″) are 100 lm. (E) The total number of follicles per mm2 in ovaries of WT
and gcNrg1KO mice at each age (n = 3 ovaries per each group). Sections taken at intervals of 30 lm and 6 lm of paraffin-embedded ovaries were mounted on slide. Follicle
numbers in 12 sections per ovary were evaluated. Values are represented as the mean  SEM of three replicates. *denotes the significant differences observed between
genotypes at the same age (P < 0.05). Different superscripts denote significant differences among the age in each genotype (P < 0.05). (F) The expression of Col3a1 in
ovaries of WT and gcNrg1KO mice. The ovaries were collected 2 days after estrus. The expression levels of genes were normalized according to that of L19. Values represent
mean  SEM of 3 replicates. The data were statistically analyzed by a two-way ANOVA. If a significant difference was observed in each factor, the comparison analysis was
performed by a Student’s t-test. Different superscripts denote significant differences among the age in each genotype (P < 0.05). *denotes significant differences observed
in each age between genotypes.
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Reduced fertility with ovarian aging, T. Umehara et al.1294
ª 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
In conclusion, the appearance and maintenance of the aberrant
endocrine cells and fibrous tissue within the ovarian stroma are
dependent on chronic high levels of LH. The accumulation of these
cells and tissue in the ovarian stroma appears to impact surrounding
secondary follicles leading to impaired follicle development by an FSH-
independent manner. That long-term treatment of GnRH antagonist
normalized the endocrine functions and matrix conditions of the ovary
and improved the fertility documents that the ovarian defects are LH-
dependent. Older women who respond poorly to exogenous FSH
treatment may, like the aged gcNrg1KO mice, have impaired follicular
development associated with reduced levels of AMH, increased fibrosis
of ovarian stroma caused by a high LH/high androgen condition, and
hence reduced fertility. By reducing LH and removing the abnormal
endocrine cells and fibrotic stromal tissue, it appears possible to reset
the ovarian–hypothalamic–pituitary axis and ovarian functions and
provides a novel strategy for improving fertility in a subset of aging
women.
Experimental procedures
Materials
Pregnant mare serum gonadotropin (PMSG/eCG) and hCG were
purchased from Asuka Seiyaku (Tokyo, Japan). Ganilelix acetate
(SML0241), GnRH antagonist, was obtained from Sigma-Aldrich (St.
Louis, MO, USA). AMV reverse transcriptase from Promega (Madison,
WI, USA), routine chemicals, and reagents were obtained from Sigma-
Aldrich or Nakarai Chemical Co (Osaka, Japan).
Animals
Conditional depletion of Nrg1 in ovarian granulosa cells (Kawashima
et al., 2014) was achieved by crossing Cyp19-Cre mice (Fan et al., 2008)
with Nrg1flox/flox mice (Yang et al., 2001). The mutant mouse strains are
in the C57BL/6 background.
Animals were housed in the Experiment Animal Center at Hiroshima
University under a 14-h light, 10-h dark schedule and provided with food
and water ad libitum. Animals were treated in accordance with the NIH
Guide for the Care and Use of Laboratory Animals, as approved by the
Animal Care and Use Committee at Hiroshima University.
Mating test
The mating experiment was conducted using five females of each
genotype (Nrg1flox/flox, WT and Nrg1flox/flox;Cyp19a1-Cre, gcNrg1KO)
that were 2 months old at the outset. Adult WT male mice were placed
in each cage for 15 months, and the number of pups in each litter and
the days of pregnancy were recorded. The dispersion of interval between
pregnancies was compared by Bartlett’s test.
Vaginal smear analysis
Vaginal smear analyses were carried out according to Rascop et al.
(1966). Smears were obtained daily between 09:00 and 10:00 am. The
fire-polished, shortened tip of a Pasteur pipet was placed at the vagina.
Morphological classification of follicles
The classification of follicles was performed according to Britt et al.
(2000). Paraffin-embedded ovarian sections taken at intervals of 30 lm
were mounted on slides. Routine hematoxylin and picrosirius red staining
were performed for histologic examination by light microscopy. Follicle
numbers in 12 sections per ovary were evaluated as primordial follicles
(oocytes surrounded by a single layer of flatness granulosa cells), primary
follicles (oocyte surrounded by a single layer of cuboidal granulosa cells),
pre-antral follicles (oocyte surrounded by two or more layers of
granulosa cells with no antrum), antral follicles (antrum within the
granulosa cell layers enclosing the oocyte), corpus luteum (the occupa-
tion of lutein cells in follicle surrounded by basal lamina), or corpus
albicans (basal lamina collapsed and lutein cells hyalinized). Follicles were
determined to be atretic if they displayed two or more of the following
criteria within a single cross section: more than two pyknotic nuclei,
granulosa cells within the antral cavity, granulosa cells pulling away from
the basement membrane, or uneven granulosa cell layers.
RNA extraction and quantitative RT–PCR analyses
Total RNA was obtained from whole ovaries using the RNAeasy Mini Kit
(Qiagen Sciences, Germantown, MD, USA) according to the manufac-
turer’s instructions. Total RNA was reverse transcribed using 500 ng
poly-dT and 0.25 U avian myeloblastosis virus reverse transcriptase at
42 °C for 75 min and 95 °C for 5 min. Quantitative real-time PCR
analyses were performed as previously (Shimada et al., 2008). Briefly,
cDNA and primers shown in Table S1 (Supporting information) were
added to 15 lL total reaction volume of the Power SYBR Green PCR
Master Mix (Applied Biosystems, Foster City, CA, USA). PCRs were then
performed using the StepOne real-time PCR system (Applied Biosys-
tems). Conditions were set to the following parameters: 10 min at 95 °C
followed by 45 cycles each of 15 s at 95 °C and 1 min at 64 °C. L19was
used as a control for reaction efficiency and variations in concentrations
of mRNA in the original RT reaction.
Immunohistochemistry
Ovaries were fixed in 4% paraformaldehyde overnight, dehydrated in
70% (v/v) ethanol, and embedded in paraffin. The paraffin-embedded
fixed sections (4 lm) were deparaffinized in xylene washes and quenched
with 3% hydrogen peroxide in methanol. The sections were incubated
with 20% (v/v) nonimmune goat serum/PBS to block nonspecific sites
Fig. 4 Heterogeneous cells that accumulate in ovarian stroma potentially have a steroidogenic activity. (A) The expression levels of Fshr, Lhr, Cyp19a1, Cyp11a1, and
Cyp17a1 in ovaries of WT or gcNrg1KO (KO) mice. The ovaries were collected 2 days after estrus. The expression levels of genes were normalized according to that of L19.
Values represent mean  SEM of three replicates. The data were statistically analyzed by a two-way ANOVA. If a significant difference was observed in each factor, the
comparison analysis was performed by a Student’s t-test. Different superscripts denote significant differences among the age in each genotype (P < 0.05). *denotes
significant differences observed in each age between genotypes. (B) The localization of the heterogeneous, CYP19-positive, CYP17-positive, and LHR-positive cells in ovaries
of 6-month-old gcNrg1KO mice. Scale bars correspond to 300 lm (9100). (C) The percent of LHR-positive cells in ovarian stroma of WT and gcNrg1KO (n = 3 in each
group). Sections taken at intervals of 30 lm and 6 lm from paraffin-embedded ovariess were mounted on slide. The sections were stained using anti-LHR antibody, and the
positive cells were cells counted. The data were statistically analyzed by a two-way ANOVA. If the significant difference was observed in each factor, the comparison analysis
was performed by a Student’s t-test. Different superscripts denote significant differences among the age in each genotype (P < 0.05). *denotes significant differences
observed in each age between genotypes.
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followed by incubation with primary antibody overnight at 4 °C (1:100 of
anti-LH receptor antibody (catalog # bs-0984); Bioss, Woburn, MA, USA;
1:100 of anti-CYP19a1 antibody (catalog # BS2516); Bioworld
Technologies, St Louis Park, MN, USA; 1:300 of anti-CYP17a1 antibody
(catalog # bs-3853); Bioss). The positive signals were visualized using
VECTASTAINE life ABC rabbit IgG kit (Vector Laboratories, Burlingame,
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Fig. 5 GnRH antagonist treatment induces apoptosis of heterogeneous cells in the ovarian stroma and restores ovarian functions in 6-month-old gcNrg1KO mice. (A) The
pattern of estrous cycles for 30 days of 6-month-old gcNrg1KO mice 7 days after GnRH antagonist treatment. Black allows show the time when the GnRH antagonist
injection was stopped. (D, diestrus; P, Proestrus; E, Estrus; WE, Weak estrus; M, Metestrus) (B) Histological analysis of ovaries collected from day 0, day 8, and day 12. The
ovaries were stained by picrosirius red and eosin. The scale bar for images in (A–F) is 400 lm. The images in the black square are higher magnification images. The scale bar
for images is 100 lm. (C) Serum levels of FSH, estrogen, testosterone, and AMH after the start of GnRH antagonist treatment. N = 4 animals for each point. Values are
represented as the mean  SEM of four replicates. *, P < 0.05, significant differences were observed compared with Day 0. (D) The number of ovulated oocytes in 6-month-
old WT, 6-month-old gcNrg1KO, and 6-month-old gcNrg1KO mice treated with GnRH antagonist. Mice at proestrus were injected ip with 5 I.U hCG. After 16 h, the
ovulated COCs were collected from oviducts and the number of ovulated COCs was counted. (E) The number of pups per delivered was calculated for each gcNrg1KO
female mouse treated with saline (KO Cont) or GnRH antagonist (KO Anta) during mating with a WT male. Three pairs were analyzed in each treatment. *denotes a
significant difference (P < 0.05). (F) The number of pups delivered during 3 months was calculated in each gcNrg1KO female mouse treated with saline (KO Cont) or GnRH
antagonist (KO Anta) during mating with a WT male. Three pairs were prepared in each treatment. *denotes a significant difference (P < 0.05).
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CA, USA) according to the manufacturer’s recommendations. The area of
anti-LH receptor antibody-positive cells in ovarian stroma was analyzed
using BZ-II application software (Keyence, Tokyo, Japan).
The detection of actin polymerization by rhodamine
phalloidin staining
Ovaries were collected and fixed in 4% paraformaldehyde, embedded in
paraffin, and processed by routine procedures as described above.
Sections were stained with rhodamine phalloidin (1:100, Invitrogen,
Carlsbad, CA, USA) at 37 °C for 60 min and then were further stained
with 40,6-diamidino-2-phenylindole (DAPI) (VECTASHIELD Mounting
Medium with DAPI; Vector Laboratories). Digital images were captured
using a BZ-9000 microscope (Keyence).
The collection of ovulated COCs and in vitro fertilization
The mice were injected intraperitoneally (ip) with 4 IU of eCG (Asuka
Seiyaku) to stimulate pre-ovulatory follicle development followed 48 h
later with 5 IU of hCG (Asuka Seiyaku) to stimulate ovulation. In vitro
fertilization was analyzed as described previously (Shimada et al.,
2008). COCs that were collected from oviduct at 16 h after hCG were
placed in 50 lL of human tubal fluid (HTF) medium. Spermatozoa were
collected from the cauda epididymis of each genotype mice into
500 lL of HTF medium. After 60-min incubation to induce sperm
capacitation, the spermatozoa were introduced into the fertilization
medium at a final concentration of 1 000 spermatozoa/lL.
Twelve hours after insemination, all gametes were further cultured
for an additional day in the developing medium (KSOM + AA,
Millipore, Billerica, MA, USA) to check for development to the
blastocyst stage.
Ovarian replacement
Ovarian replacement was performed according to Pakarainen et al.
(2005). Briefly, the mice were anesthetized with 100 lL of 20%
pentobarbital. Both ovaries were removed surgically from the bursa
surrounding ovaries and each was replaced with ovaries from another
donor mouse, and skin was sutured after the operation.
Long-term treatment of GnRH antagonist
Injections of 50 lg/kg BW of GnRH antagonist (Sigma-Aldrich) were
given daily at 09:00 am. With the injection of GnRH antagonist, smear
analysis was carried out and the injection was stopped when diestrus
periods was observed. The mice after injection were mated with 3-
month-old WT male mice for 3 months, and the number of pups and
deliver was record.
Measurement of AMH, FSH, LH, testosterone, inhibin B,
estradiol, and progesterone
Serum levels of AMH were measured using mouse AMH ELISA kit
(Elabscience Biotechnology, Bethesda, MD, USA); serum FSH was
measured using the FSH ELISA kit (Abnova, Taipei, Taiwan); and serum
LH, testosterone, estradiol, and progesterone were measured using
specific ELISA kits (Endocrine Technology, Inc, Newark, CA, USA). Inhibin
B was measured using the mouse Inhibin B Enzyme Immunoassay Kit
(RayBiotech, Norcross, GA, USA). All measurements were taken accord-
ing to the manufacturer’s instructions.
Statistics
Statistical analyses of data from three or four replicates for comparison
were carried out by either Student’s t-test or one-way ANOVA followed
by Student’s t-test (Statview; Abacus Concepts, Inc., Berkeley, CA, USA).
In Figure 3 and Figure 4, the data obtained from three different cultures
were carried out by a two-way ANOVA (Statview; Abacus Concepts, Inc).
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Fig. S1 The patterns of estrous cycles were determined by vaginal smear
analysis for 15 days.
Fig. S2 Serum levels of FSH, LH, estradiol, testosterone, and inhibin B in WT
and gcNrg1KO.
Fig. S3 (A) Low magnification images stained using rhodamine phalloidin
and DAPI with constant settings that were established for the 12-month old
gcNrg1KO. (B) An image of the ovary in 12-month-old gcNrg1KO mice
stained without rhodamine phalloidin. Scale bars correspond to 300 lm.
Fig. S4 The number of follicles at each stage of development per mm2 in
ovaries of WT and gcNrg1KO mice at each age (n = 3 ovaries per each
group).
Fig. S5 (A) The expression of CYP19, CYP17 and LHR in ovaries 48 h after
eCG treatment. (B) Image of an ovary in a 6-month-old gcNrg1KO mouse
stained without primary antibody.
Fig. S6 (A) The appearance of cleaved caspase 3-positive cells, LHR-positive
cells or CYP19-positive cells in the ovarian stroma. (B) The percent of each
stage of secondary follicle (assessed by layers) in ovaries of 6-month-old WT,
6-month-old gcNrg1KO, and 6-month-old gcNrg1KO mice treated with the
GnRH-antagonist.
Fig. S7 (A) Estrous cycle patterns analyzed for 13 days in 12-month-old WT
mice injected with GnRH-antagonist (D, diestrus P, Proestrus E, Estrus WE,
Weak estrus M, Metestrus). (B) The number of pups per delivery was
calculated in 12-month-old WT treated with saline (12 mon WT Cont) or
GnRH-antagonist (12 mon WT Anta). (C) The number of pups delivered
during 3 months was calculated in 12-month-old WT mice treated with
saline (12 mon WT Cont) or GnRH-antagonist (12 mon WT Anta).
Table S1 List of primers employed for RT-PCR and the expected size.
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